QF Entity participation in clinical trials leads to approval of the Venus P-Valve for worldwide use 08 November 2022, Doha, Qatar – Sidra Medicine has been selected as the first hospital in the
QF Entity cares for over 500 international patients in five years 02 November 2022, Doha, Qatar – Surgeons from Sidra Medicine performed a life-saving procedure on an international patient from Uganda, highlighting its
25 October 2022, Doha, Qatar – Sidra Medicine has signed a memorandum of understanding (MoU) with Microsoft to facilitate its research division’s digital transformation goals and accelerate its precision medicine and genomics research
QF Entity coincides new service opening with World Menopause Day 18 October 2022, Doha, Qatar – Sidra Medicine has launched a new Menopause Clinic, a comprehensive service dedicated to the management of women’s
QF Entity to focus on women’s wellness within a holistic context 4 October 2022, Doha, Qatar – Sidra Medicine will virtually host a Women’s Health Conference (WHC 2022) from 14-15 October 2022. The conference will
29 September 2022, Doha, Qatar – Sidra Medicine successfully concluded its Precision Medicine Functional Genomics symposium (PMFG 2022) to a packed audience of over 640 registered attendees during the course of the four-day
QF Entity study highlights precision medicine approach to guide treatment for certain childhood cancers 21 September 2022, Doha, Qatar – Researchers from Human Immunology in collaboration with the Anatomic Pathology and
QF Entity Appointed as Lead Treatment Center in MENA to administer life-saving SMA drug for babies 14 September 2022, Doha, Qatar – The Genetics and Genomic division at Sidra Medicine has launched several
QF Entity pioneering interventional valve implantation shared as successful methodology to treat CHD patients 11 September 2022, Doha, Qatar – Sidra Medicine has showcased its latest surgical and clinical research milestones at
